Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Interview with Mark Frasier: a Michael J Fox Foundation perspective on precision medicine in Parkinson's.

Frasier MA.

Per Med. 2017 Jan;14(1):13-15. doi: 10.2217/pme-2016-0087. Epub 2016 Nov 30.


Parkinson's disease is ready for precision medicine.

Sherer TB, Frasier MA, Langston JW, Fiske BK.

Per Med. 2016 Sep;13(5):405-407. doi: 10.2217/pme-2016-0052. Epub 2016 Aug 9. No abstract available.


Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease.

Dave KD, De Silva S, Sheth NP, Ramboz S, Beck MJ, Quang C, Switzer RC 3rd, Ahmad SO, Sunkin SM, Walker D, Cui X, Fisher DA, McCoy AM, Gamber K, Ding X, Goldberg MS, Benkovic SA, Haupt M, Baptista MA, Fiske BK, Sherer TB, Frasier MA.

Neurobiol Dis. 2014 Oct;70:190-203. doi: 10.1016/j.nbd.2014.06.009. Epub 2014 Jun 24.


Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organs.

Baptista MA, Dave KD, Frasier MA, Sherer TB, Greeley M, Beck MJ, Varsho JS, Parker GA, Moore C, Churchill MJ, Meshul CK, Fiske BK.

PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013.


α-synuclein imaging: a critical need for Parkinson's disease research.

Eberling JL, Dave KD, Frasier MA.

J Parkinsons Dis. 2013;3(4):565-7. doi: 10.3233/JPD-130247.


A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's Research.

Baptista MA, Dave KD, Sheth NP, De Silva SN, Carlson KM, Aziz YN, Fiske BK, Sherer TB, Frasier MA.

Dis Model Mech. 2013 Nov;6(6):1316-24. doi: 10.1242/dmm.011940. Epub 2013 Sep 12.


Special focus section: gene therapy for Parkinson's disease.

Fiske BK, Frasier MA, Sherer TB.

Exp Neurol. 2008 Jan;209(1):28-9. Epub 2007 Sep 18. No abstract available.


Supplemental Content

Loading ...
Support Center